Literature DB >> 10904116

Complement components of the innate immune system in health and disease in the CNS.

P Gasque1, Y D Dean, E P McGreal, J VanBeek, B P Morgan.   

Abstract

The innate immune system and notably the complement (C) system play important roles in host defense to recognise and kill deleterious invaders or toxic entities, but activation at inappropriate sites or to an excessive degree can cause severe tissue damage. C has been implicated as a factor in the exacerbation and propagation of tissue injury in numerous diseases including neurodegenerative disorders. In this article, we review the evidence indicating that brain cells can synthesise a full lytic C system and also express specific C inhibitors (to protect from C activation and C lysis) and C receptors (involved in cell activation, chemotaxis and phagocytosis). We also summarise the mechanisms involved in the antibody-independent activation of the classical pathway of C in Alzheimer's disease, Huntington's disease and Pick's disease. Although the primary role of C activation on a target cell is to induce cell lysis (particularly of neurons), we present evidence indicating that C (C3a, C5a, sublytic level of C5b-9) may also be involved in pro- as well as anti-inflammatory activities. Moreover, we discuss evidence suggesting that local C activation may contribute to tissue remodelling activities during repair in the CNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10904116     DOI: 10.1016/s0162-3109(00)80302-1

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  96 in total

Review 1.  Complement in central nervous system inflammation.

Authors:  Scott R Barnum
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Complement-induced impairment of the innate immune system during sepsis.

Authors:  Eric A Albrecht; Peter A Ward
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

Review 3.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

4.  Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2011-11       Impact factor: 1.831

5.  Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury.

Authors:  Mauricio E Vargas; Junryo Watanabe; Simar J Singh; William H Robinson; Ben A Barres
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

6.  Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia.

Authors:  Stephen J Glatt; Ian P Everall; William S Kremen; Jacques Corbeil; Roman Sásik; Negar Khanlou; Mark Han; Choong-Chin Liew; Ming T Tsuang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-13       Impact factor: 11.205

7.  Complement-induced Impairment of the Innate Immune System During Sepsis.

Authors:  Eric A Albrecht; Peter A Ward
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

Review 8.  [Traumatic brain injury: impact on timing and modality of fracture care].

Authors:  P F Stahel; W Ertel; C E Heyde
Journal:  Orthopade       Date:  2005-09       Impact factor: 1.087

9.  Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.

Authors:  Yuhsuke Ohmi; Orie Tajima; Yuki Ohkawa; Atsushi Mori; Yasuo Sugiura; Keiko Furukawa; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

10.  Identification of genes involved in the host response to enterovirus 71 infection.

Authors:  Shin-Ru Shih; Victor Stollar; Jing-Yi Lin; Shih-Cheng Chang; Guang-Wu Chen; Mei-Ling Li
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.